Related Experiment Video
Updated: Oct 14, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
Kyle Rosenke1, Friederike Feldmann2, Atsushi Okumura1
1Laboratory of Virology, Hamilton, MT, USA.
Abstract:
The continuing emergence of SARS-CoV-2 variants calls for regular assessment to identify differences in viral replication, shedding and associated disease. In this study, we compared African green monkeys infected intranasally with either the UK B.1.1.7 (Alpha) variant or its contemporary D614G progenitor. Both variants caused mild respiratory disease with no significant differences in clinical presentation. Significantly higher levels of viral RNA and infectious virus were found in upper and lower respiratory tract samples and tissues from B.1.1.7 infected animals. Interestingly, D614G infected animals showed significantly higher levels of viral RNA and infectious virus in rectal swabs and gastrointestinal tissues. Our results indicate that B.1.1.7 infection in African green monkeys is associated with increased respiratory replication and shedding but no disease enhancement similar to human B.1.1.7 cases.
Insights
The SARS-CoV-2 Alpha variant (B.1.1.7) increased respiratory replication in monkeys but did not worsen disease. The D614G variant showed more gastrointestinal shedding.
Area of Science:
- Virology
- Infectious Diseases
- Comparative Pathology
Background:
- Emerging SARS-CoV-2 variants necessitate evaluating differences in replication, shedding, and disease.
- The B.1.1.7 (Alpha) variant and D614G progenitor are key SARS-CoV-2 strains.
Purpose of the Study:
- To compare the replication and disease potential of the SARS-CoV-2 B.1.1.7 variant versus its D614G progenitor in African green monkeys.
- To assess differences in viral shedding and tissue tropism between these variants.
Main Methods:
- African green monkeys were intranasally inoculated with either the B.1.1.7 or D614G SARS-CoV-2 variant.
- Clinical presentation, viral RNA levels, and infectious virus titers were measured in respiratory, gastrointestinal, and rectal samples.
- Viral RNA and infectious virus loads were quantified in various tissue samples.
Main Results:
- Both B.1.1.7 and D614G variants caused mild respiratory disease with no significant clinical differences.
- B.1.1.7 infected animals exhibited significantly higher viral RNA and infectious virus levels in the respiratory tract.
- D614G infected animals showed significantly higher viral RNA and infectious virus levels in rectal swabs and gastrointestinal tissues.
Conclusions:
- SARS-CoV-2 B.1.1.7 variant infection in African green monkeys is linked to enhanced respiratory replication and shedding.
- No significant disease enhancement was observed for the B.1.1.7 variant in this model, mirroring human observations.
- Differential tropism was observed, with B.1.1.7 favoring the respiratory tract and D614G showing increased gastrointestinal involvement.
Related Concept Videos
Viral Mutations
Viral Recombination
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs

